APA Alıntı

Funakoshi-Tago, M., Yu, S., Kushida, A., Takeuchi, K., & Tamura, H. (2020). Kampo medicines, Rokumigan, Hachimijiogan, and Goshajinkigan, significantly inhibit glucagon-induced CREB activation. Heliyon.

Chicago Stili Alıntı

Funakoshi-Tago, Megumi, Seisho Yu, Akira Kushida, Kazusane Takeuchi, ve Hiroomi Tamura. "Kampo Medicines, Rokumigan, Hachimijiogan, and Goshajinkigan, Significantly Inhibit Glucagon-induced CREB Activation." Heliyon 2020.

MLA Alıntı

Funakoshi-Tago, Megumi, et al. "Kampo Medicines, Rokumigan, Hachimijiogan, and Goshajinkigan, Significantly Inhibit Glucagon-induced CREB Activation." Heliyon 2020.